Background: Many pathogens secrete effector molecules to subvert host immune responses, to acquire nutrients, and/or to prepare host cells for invasion.
Introduction
Plasmodium falciparum malaria remains a major public health problem, with 212 million cases of malaria and half a million deaths due to severe malaria reported worldwide in 2015 1 . The pathogenesis mechanism of severe malaria is not completely understood, but relevant factors include parasite burden 2 , induction of host inflammatory responses 3 , and obstruction of movement of blood in the microvasculature of important organs such as the brain due to adhesion of parasite infected erythrocytes (IEs) to vascular endothelial cells 4 . Binding of IEs to vascular endothelial cells through endothelial protein C receptor (EPCR) has been hypothesized to cause endothelial activation and inflammation, contributing to pathogenesis 5, 6 . However, results from other studies suggest that endothelial activation and inflammation during malaria parasite infections can be independent of cytoadhesion of IEs 7-9 , and effectors secreted by the parasite have been suggested to play a more important role 7, [10] [11] [12] .
One way secreted effectors are released from cells is through extracellular vesicles (EVs) that can be classified into two major types; exosomes and microvesicles 13, 14 . Exosomes are vesicles of endocytic origin with diameter of 30-150 nm released to the extracellular space when the endosomal multivesicular body (MVB) merges with plasma membrane of the cell 15 . By contrast, microvesicles are larger, with a diameter of 100-1000nm, and are generated through outward invagination of the plasma membrane 16 . These vesicles can transfer biologically active effector molecules such as lipids, nucleic acids, metabolites and proteins from one cell to another thereby modifying the properties of the recipient cells 13, 14, 17, 18 . The physiological significance of these vesicles is becoming increasingly appreciated in many disease processes, including cancer 14, [19] [20] [21] and infectious diseases 12, [22] [23] [24] [25] [26] .
Increasing evidence suggests that secreted extracellular vesicles (EVs) play an important role in intercellular communications 12, 13, 19, 22, [26] [27] [28] [29] [30] [31] . In the context of cancer and infectious diseases, EVs can be used to sabotage the host defence mechanism 26, [32] [33] [34] [35] [36] , prepare the host cell for invasion 19, 20, 27, 37, 38 and acquire nutrients from the environment [39] [40] [41] [42] . Identifying the content of EVs released by pathogenic organisms will help to understand their basic biology, and potentially identify targets for intervention or diagnostics.
In malaria, P. falciparum EVs (PfEVs) have only been recently identified in two studies that used long-term laboratory isolates, and it has been proposed that PfEVs play a role in cell-cell communications and gametocytogenesis 12, 22 . As EVs represent an extended phenotype of the cell 14 , unravelling the bioactive molecules in PfEVs will contribute to our understanding of the biology and virulence mechanisms of P. falciparum. Analogy with other pathogens would suggest that P. falciparum exosomes may play a role in immunomodulation, nutrient acquisition and invasion in vivo. Given that long-term P. falciparum laboratory strains, such as 3D7, have not been exposed to the human host environment for decades, it is possible that they may have adapted to release fewer PfEVs or pack a less extensive set of effectors into them, whereas more recently culture adapted P. falciparum clinical isolates might release PfEVs containing a greater variety and depth of effectors.
Here we present analysis of the protein content of PfEVs isolated from a Kenyan clinical isolate that has been grown in vitro for a shorter period than established laboratory strains, and compare it with published Plasmodium EV proteome datasets to define a core Plasmodium EV content.
Materials and methods

Parasite culture
The Kenyan isolate (referred to as isolate 9605) 43 was obtained from a child admitted to Kilifi County Hospital with cerebral malaria in 2009. The parasite was adapted to in vitro culture and at the time of conducting this study the parasite had been grown in vitro for a maximum of 70 cycles, as opposed to many years in the case of most laboratory isolates such as 3D7. The genome of this isolate was sequenced using both Illumina and PacBio platforms at the Wellcome Trust Sanger Institute, Hinxton, Cambridge, (manuscript in preparation). With the publication of the genome, the isolate will be made available to the community through the European malaria reagents repository (http://www.malariaresearch.eu/reagents), University of Edinburgh. Parasite culture was carried out under standard conditions 44 .
Preparation of P. falciparum culture-conditioned media P. falciparum 9605 culture was tightly synchronised by repeated sorbitol treatment and expanded to 6 flasks, each containing 500 µl packed cells at 5-10% parasitemia. RPMI culture media supplemented with AlbumaxII (Gibco) was used to grow the parasite. Albumaxll was depleted of exosomes by centrifuging at 150,000g for 2 hours. 50ml of the media was added to each flask when parasites were at early ring stages and harvested after 24 hours when the parasite grew to mature trophozoites (referred to as the ring-to-trophozoite, or RT sample). The culture was diluted with fresh blood (supplied by NHS, Cambridgeshire, UK) to maintain parasitemia within 5-10% in the following cycle. Fresh media was added and then harvested again 24 hours later, when the parasites had returned to early ring stage (referred to as the trophozoite-to-ring, or TR sample). Culture-conditioned media harvested at each step was processed as outlined in Figure 1 . The culture was transferred to 50ml Falcon tubes and centrifuged at 440g for 5 minutes to pellet the erythrocytes. The supernatant culture-conditioned media was centrifuged one more time at 440g for 5 minutes, then twice at 2000g for 10 minutes, once at 3600g for 10 minutes, and finally at 15000g for 30 minutes, each time using new 50ml Falcon tube. The pellet obtained after the 15000g spin was stored at -80°C for future analysis, as it potentially contains microvesicles. The supernatant, presumed to predominantly contain exosomes, was filtered at 0.2µm and the flow-through frozen at -80°C until use.
Purification of Pf EVs by density gradient ultracentrifugation
To purify PfEVs, the frozen supernatant generated above was thawed on ice and loaded on quick-seal ultracentrifugation tubes (Bechman Coulter cat# 343322), then centrifuged at 150, 000g for 2hrs using an Optima XE90 ultracentrifuge and 70.1Ti rotor (Beckman Coulter). The pellet was washed twice by re-suspending in cold PBS and centrifuging at 150,000g for 2 hours after each wash. The final pellet was loaded onto OptiPrep™ density gradient Figure 1 . Isolation of PfEVs. A). Schematic showing the steps followed to purify Pf EVs. B). Transmission electron microscopy was used to confirm the presence of vesicles in the pellet. The sizes ranged between 27-411nm with median of 132 and mean±SD of 143nm≥66). 73% were below 150nm and 90% were below 200 nm. C). Protein extract from each of the density gradient fraction was run on SDS-PAGE gel and stained with silver. The common band is albumin and lanes 9, 10 and 11 corresponding to fractions 10,11 and 12 seem to contain exosome proteins. This gel only shows analysis of Pf EVs from TR time point. The original uncropped image for both RT and TR time points is available at https://osf.io/wdg96/ 75 .
medium prepared as described [45] [46] [47] and centrifuged at 250,000g for 18 hours. 1ml fractions were collected from the top of the gradient into 1.5ml Eppendorf tubes. To estimate the density of the purified vesicles, the weights of the tubes containing the fractions were measured using weighing machine (Sartorius, PB221S). Each fraction was diluted in PBS to 13.5 ml and centrifuged at 150, 000g for 2 hours and the pellet re-suspended in 400 µl of 8M urea, 2.5% SDS in 50 mM phosphate buffer, pH 8.0 to extract proteins, before concentrating using a 3KDa MWCO concentrator (Pierce™). A fifth of each fraction was analysed for the presence of proteins by running on SDS-PAGE and staining using silver stain (Bio-Rad).
Proteomic analysis by mass spectrometry Fractions confirmed to contain PfEV proteins by silver staining were first reduced by adding DTT to final concentration of 5mM for 10 minutes at 70 °C, then alkylated by adding iodoacetamide (IAA) to final concentration of 10 mM and incubated for 30 minutes at room temperature in the dark. The samples were then separated by SDS-PAGE (NuPAGE 4-12% Bis-Tris Gel, Life Technology). The gel was fixed in 40% methanol/2% acetic acid for 30 minutes, stained with colloidal Coomassie (Sigma) overnight, and finally destained with 30% methanol until the background was cleared. Each lane was excised to four pieces, and the gel pieces were destained in 50 mM ammonium bicarbonate/50% CH 3 CN until the gel pieces were completely destained, then they were digested by trypsin (Pierce MS Grade, Thermo Fisher Scientific) overnight at 37°C. Peptides were extracted with 0.5% formic acid (FA)/50% CH 3 CN and dried in a SpeedVac (Thermo Fisher Scientific). The peptides were resuspended in 20 µl of 0.5% FA just before LC-MS/MS analysis on a LTQ Orbitrap Velos (Thermo Fisher) hybrid mass spectrometer equipped with a nanospray source, coupled with an Ultimate 3000 RSLCnano System. Samples were first loaded and desalted on a PepMap C18 trap (0.1 mm id × 20 mm, 5µm) at 10 µL/min for 15 min, then peptides were separated on a 75 µm id x 25 cm PepMap column (3 µm) at a flow rate of 300 nl/min over a 90 min linear gradient of 4-32% CH 3 CN/0.1% FA, 130 min/cycle. All instrument and columns were from Thermo Fisher Scientific. The LTQ Orbitrap Velos was operated in the "Top 15" data-dependant acquisition mode. The 15 most abundant and multiply-charged precursor ions in the MS survey scan in the Orbitrap (m/z 380 -1600, with the lock mass at 445.120025) were dynamically selected for CID fragmentation (MS/MS) in the LTQ Velos ion trap. The ions must have a minimal signal above 3000 counts. The preview mode of FT master scan was disabled. The Orbitrap resolution was set at 30,000 at m/z 400 with one microscans. The isolation width for the precursor ion was set at 2 Th. The normalized collision energy was set at 35% with activation Q at 0.250 and activation time for 10 msec. The dynamic exclusion mass width was set at ±10 ppm and exclusion duration for 60 seconds. To achieve high mass accuracy, the AGC (Automatic Gain Control) were set at 1×10 6 for the full MS survey in the Orbitrap with a maximum injection time at 150 msec, and 5000 for the MS/MS in the LTQ Velos with a maximum injection time at 100 msec.
The raw files were processed in MaxQuant (Version 1.5.3.30, www.MaxQuant.org), and searched against the Plasmodium falciparum 3D7 and 9605 protein databases, human protein database (from UniprotKB, October 2014, www.uniprot.org), and a contaminate database supplied by MaxQuant. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 48 partner repository, with the dataset identifier PXD006925.
. Parameters used were mainly in default values, with some modifications: trypsin with maximum 2 missed cleavages sites; peptide mass tolerance at first search was set at 20 ppm and main search was at 4.5 ppm; MS/MS fragment mass tolerance at 0.50 Da, and top 8 MS/MS peaks per 100 Da and a minimum peptide length of 7 amino acids were required. Fixed modification for Carbamidomethyl and variable modification for Acetyl (Protein N-term), Deamidated (NQ) and Oxidation (M) were used. False discovery rates (FDR) were estimated based on matches to reversed sequences in the concatenated target-decoy database. The maximum FDR at 1% was allowed for both proteins and PSMs. Peptides were assigned to protein groups, a cluster of a leading protein(s) plus additional proteins matching to a subset of the same peptides.
Gene ontology (GO) enrichment analysis
To assess whether certain classes of proteins are enriched in PfEVs proteome, gene ontology analysis for enrichment of cellular components was carried out using PlasmoDB (http:// plasmodb.org/plasmo/showApplication.do).
Results
Vesicles with features characteristics of exosomes can be purified from culture conditioned media of a recently adapted P. falciparum isolate We isolated PfEVs from culture-conditioned media of a Kenyan P. falciparum clinical isolate adapted to in vitro culture. Cultureconditioned media was harvested as shown in Figure 1a , and vesicles pelleted using ultracentrifugation. Examining the pellet by transmission electron microscopy revealed vesicles (Figure 1b ) with median size of 132nm, mean±SD of 143nm±66. To further purify the pelleted vesicles, the pellet was re-suspended in PBS and subjected to OptiPrep density gradient ultracentrifugation as described in the Methods. 1ml fractions drawn from the top of the gradient were collected, and as shown in Figure 1c , lane 9, 10, and 11 (corresponding to fractions 10, 11, and 12) contained several protein bands, whereas the rest of the fractions contained a single band representing albumin, a common contaminant co-pelleted with EVs. The density of the fractions 10, 11, and 12 ranged between 1.06-1.17g/cm 3 , consistent with the range described for exosomes (1.08-1.22 g/cm 3 ) 49 .
The purified vesicles contained both host and parasite proteins To identify the protein content in the isolated PfEVs, fractions identified as containing proteins through silver-staining ( Figure 1c) were run on an SDS-PAGE gel and stained by colloidal Coomassie. Each lane was cut into four pieces and processed for mass spectrometry analysis as described in the Methods. 153 P. falciparum proteins (Table S1 ) and few erythrocyte proteins such as haemoglobin (alpha and beta chains), band 3 anion transport protein, erythrocyte band 7 integral membrane protein, and spectrin were identified. Serum/albumax and other common contaminants were excluded from the analysis.
Virulence associated parasite proteins were among the protein class significantly enriched in the Pf EVs proteome We identified 61 and 149 P. falciparum proteins in the PfEVs purified from the culture conditioned media of ring-to-trophozoite (RT) and trophozoite-to-rings (TR) time points, respectively (Table S1 ). 57 of the 61 parasite proteins in the RT time point were also present in the TR, showing reproducibility of enrichment methods and giving a total of 153 P. falciparum proteins (Table S1 ). GO term enrichment analysis for cellular components revealed that terms related to proteins commonly found in EVs such as ribosomes were significantly enriched in Pf EVs (Figure 2a ). In addition, terms related to virulence associated parasite specific proteins were also significantly enriched ( Figure 2a ). The virulence associated proteins included proteins residents in membrane bound organelles that form in the IE cytosol such as Maurer's clefts (MCs), and merozoite secretory organelles such as the rhoptry, the microneme and the dense granules ( Figure 2a ). In contrast, GO-terms associated with proteins of intracellular organelles such as nucleus, ER, and mitochondria were not significantly enriched in the PfEVs proteome (Figure 2a ). Among the apically associated proteins, rhoptry associated proteins were the most dominant (Figure 2a) . PfEVs from the RT sample were enriched for proteins found in exomembrane compartments of the IEs (Table S1 ).
Parasite proteins found in membrane-bound organelles from IE cytosol and the merozoite were the most abundant PfEV proteins When the list of PfEV proteins was stratified by the number of unique peptides, the top 50 most abundant (≥4 unique peptides) were parasite proteins that are exported to exomembrane compartments within the infected erythrocytes beyond the parasite plasma membrane (Figure 2b and Table S1 ). Proteins found across this exomembrane network, including MCs (SBP1, REX1/2, MAHRP1/2 and PfMC-2TM), J-dots (PfHSP40 and PfHSP70-x), IE membrane (Glag3.1, RhopH3, RESA, KAHRP, PfEMP3) and parasitophorus membrane (PTEX complex, ETRAMP family) were identified (Table S1 ). Interestingly while REX1/2, two proteins localised in the MCs 50 were detected in the PfEVs proteome, REX3, which localises in the IE cytosol 50 as a soluble protein, was not detected. Further, PfHRP2 which is secreted into the extracellular space as a soluble protein was also not detected, suggesting most parasite proteins identified in the proteomic analysis are associated with membranes.
Several multigene family proteins such as PfEMP1, Rifins, Stevor, PHIST and FIKK are exported to or via these exomembrane compartments. Among these multigene protein families, PHIST and Rifin families were represented in PfEVs (Table S1 and  Table S2 ) but no PfEMP1 and Stevor proteins were detected, consistent with previous finding by Mantel et al. 12 . This is despite the presence of other proteins that localise at the knobs beneath the IE surface membrane, such as KAHRP and PfEMP3, and Gene Ontology enrichment analysis for cellular components (N=153). Plotted is the -log p-value (Bonferroni adjusted for 56 comparisons) against the GO terms. The horizontal red line indicates the cut-off for significance (p<0.01). The most significant GO terms were associated with ribosomal, exported and invasion genes (apical complex). Note the invasion related genes are denominated by rhoptry genes (green bar, highlighted with blue line), especially the rhoptry bulb. The rhoptry has been hypothesized to be the equivalent of the endosomal multivesicular body containing vesicles to be secreted to the extracellular environment as exosomes. Enrichment for genes related to intracellular organelles (purple bars) such as mitochondria, ER and nuclear was not significant. B). GO-terms associated with the top 50 most abundant proteins (#unique peptide≥4). Plotted is the -log p-value (Bonferroni adjusted for 38 comparisons) against the GO terms. Genes exported to the vesicular compartments within the cytosol of the parasitized red blood cells and those secreted from the endomembrane compartments of the merozoites such as the rhoptry and dense granules were the most abundant genes.
proteins linked to transport of PfEMP1 to the surface of the IE (PTP1, PTP6) 51 . These observations suggest that PfEVs are not derived from the IE plasma membrane.
The second most abundant class of parasite proteins enriched in PfEVs was merozoite antigens discharged from the secretory endomembranous compartments of the apical end (Figure 2b and Table S1 ). The rhoptry proteins were the most enriched (Figure 2 and Table S1 ). These include the RhopH complex (RhopH1 (Clag3.1) RhopH2 and RhopH3), the RAP complex (RAP2 and RAP3), RALP1 and RON3. Notably, these proteins are found in the bulb of the rhoptry organelle. Except for RON2, proteins from the rhoptry neck region, such as other RONs or members of the reticulocyte binding protein homologue (PfRh) family except RH4, were not detected. Some microneme resident proteins such as EBA-175 and EBA-181 were also present (Table S1 ) but notably absent was AMA1, consistent with a previous report 12 . Several dense granule proteins released during merozoite invasion were also among the most abundant PfEVs proteins. These included those that contribute to establishment of a translocon at the PVM for protein export (PTEX members; HSP101, PTEX150, and EXP2) and proteins exported into the invaded erythrocyte early after invasion (SBP1, RESA, MAHRP1).
Comparing Pf EVs datasets to define a core Pf EV proteome The proteomic data of the Kenyan clinical isolate had substantial overlap with the only previously published PfEVs proteome 12 but was significantly deeper. Between these two studies there are now 184 PfEV proteins identified. 53/84 proteins detected by Mantel et al 12 were common to our Kenyan isolate and 100 proteins (54% of the 184) were unique to our clinical isolate (Figure 3a) . GO term enrichment analysis based on cellular components revealed that the PfEVs proteins shared between the Kenyan and the long-term laboratory isolates were dominated by virulence associated proteins found in secretory membranous compartment of the merozoite or the cytosol of the IE suggesting that these class of parasite proteins form the core PfEV proteome (Figure3b). The PfEV proteins detected only in the Kenyan isolate were enriched for ribosomal and virulence associated exomembrane proteins (Figure 3c ). (Mantel et al 12 ), but was also significantly deeper, covering more proteins. B). GO-terms enrichment analysis for cellular components of the PfEVs proteins common in both the Kenyan and the long-term laboratory isolates used in Mantel et al 12 .
Plotted is the -log p-value (Bonferroni adjusted for 53 comparisons) against the GO terms. GO terms associated with exported and invasion related proteins were significantly enriched. C). GO-term enrichment analysis showing that the PfEV proteins specific to the Kenyan isolate. Plotted is the -log p-value (Bonferroni adjusted for 46 comparisons) against the GO terms.
Discussion
In this study, we characterised the protein content of EVs released by a Kenyan P. falciparum clinical isolate, 9605. We show that these PfEVs have physical characteristics close to exosomes, and proteomics identified 153 P. falciparum proteins, of which the most abundant were virulence associated proteins.
Previous proteomic analysis of PfEVs from long-term laboratory isolates identified 84 P. falciparum proteins 12 . The expanded list identified here suggests that the protein content of PfEVs from clinical isolates might be broader than that of long-term laboratory isolates. While analysis of further long and short-term laboratoryadapted isolates will be required to formally test this hypothesis, it is well known that long-term laboratory P. falciparum isolates can down-regulate genes involved in pathogenesis in vivo but are not required for in vitro culture, such as genes associated with cytoadherence. For example, the common laboratory isolate 3D7 predominantly expresses only a limited number of var genes 52 which encode for the variant surface antigen required for sequestration. Further, genes encoding for exported and sexual stage proteins have been shown to be upregulated in short-term culture adapted clinical isolates (48-86 in vitro cycles) as compared to long-term laboratory isolates 53 . Therefore, due to the relatively shorter time the Kenyan isolate spent in in vitro culture conditions, 9605-PfEVs proteome may represent a closer reflection of that released by the parasite under in vivo condition. Caution is required of course, and technical differences in EV purification or proteomic detection between studies clearly cannot be ruled out as the cause of the differences observed. More studies of PfEVs from clinical isolates is clearly required.
The biogenesis of PfEVs is not known, but this proteomic analysis revealed several parasite proteins with potential role in biogenesis and transport of endosomal vesicles. These include Rab GTPases (PfRab7, PfRab6), and P. falciparum pyruvate kinase (PfPK) (Table S2) , which in other systems are required for transport 54 as well as release of exosomes
55
. The apicomplexan Rab11A has been speculated to be involved in the transport of vesicles derived from endosome-like compartments 56 . In addition, the most abundant proteins were from exomembrane compartments of the IEs 57 (Figure2), suggesting an origin in these vesicular compartments. Previous immunoprecipitation of an MCs resident protein SEMP1 58 , which is also among the most abundant PfEVs proteins (Table S1 ), co-precipitated 14 proteins of which 13 were identified here as being present in PfEVs (Table S1/ . Functional analysis of the P. falciparum genes described here may therefore shed more light on the process of PfEVs biogenesis and release.
Another vesicular compartment closely linked to PfEVs is the secretory endomembrane compartments of the merozoite apical end, such as the dense granules and the rhoptry. Proteins from the rhoptry, specifically those from the rhoptry bulb region, were among the most dominant identified (Table S2 ). The rhoptry bulb has a honeycomb appearance by transmission microscopy, which has been postulated to be formed by internal membranes and/or vesicles 59 , and it has been further hypothesised that the rhoptry might be the equivalent of multivesicular body (MVB) in higher eukaryotes 60 . It is therefore possible that the content of the merozoite endomembrane compartments particularly those of the rhoptry and the dense granules are secreted as EVs. This possibility is supported by a recent study that showed 50% of RhopH3 is released into the culture media during merozoite invasion as insoluble membrane-associated protein that can only be pelleted down from the culture media by ultracentrifugation 61 , which could well be PfEVs. Further, antibody targeting PTEX150 released from dense granules 62 precipitated 82 parasite proteins 63 , of which 42 (51%) are present in PfEVs (Table S2 ). The possibility that key components required for early establishment of the exomembrane compartments such as PTEX [64] [65] [66] , RAP 67 , and RhopH 61,68,69 complexes are in part secreted in vesicles will be important to confirm using immunoelectron microscopy.
Previously, typical intracellular Plasmodium antigens have been proposed as potential subunit vaccine candidates including some identified in screens of large panel of P. falciparum proteins using plasma from malaria exposed individuals [70] [71] [72] . PfEVs contain several of these antigens (Table S2 ) which might explain how they become accessible to the host immune system 73 . Further, immunisation of mice with P. yoelii EVs provided protection against lethal infection 24, 74 and data in PlasmoDB shows a high proportion of the genes encoding parasite proteins in PfEVs have a nonsynonymous to synonymous mutations ratio (dN /dS) of above 1 (Table S2 ), suggesting they might be under host immune pressure.
Conclusions
In summary, we have purified PfEVs with physical characteristics of exosomes from a short-term adapted Kenyan clinical isolate. Proteomic analysis broadened the list of PfEVs components, and suggests that PfEVs are closely linked to exomembrane and endomembrane compartments in the IEs and merozoites. We hypothesize that, in addition to the parasite-parasite communication role described before 12, 22 , PfEVs might have a role in fine-tuning the host immune response, preparing the host cell for invasion and acquiring nutrients from the environment. Further functional validation of PfEVs components, and expanded study of PfEVs protein, RNA, lipid and metabolite content from a range of isolates, is clearly required.
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